Exabis Library
Welcome to the e-CCO Library!
P063: Host-mycobiome interactions during the resolution of inflammation in experimental colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P063: Representative and comprehensive analysis of colonic and ileac biopsies from IBD patients by gene expression profiling using the straightforward, fast, and affordable novel application Whole Transcriptome AmpliSeq on the Ion Torrent NGS platform
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P063: The immunological landscape of intestinal fibrosis in Crohn’s Disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P064 Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P064: 3-oxo-C12:2, a Quorum Sensing molecule from the gut, exerts anti-inflammatory effects through a bitter taste receptor
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P064: EBI2 and oxysterols in the development of intestinal lymphoid structures and colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P064: High intestinal Secretory Leukocyte Protease Inhibitor (SLPI) expression correlates with abundant neutrophilic inflammation and identifies Inflammatory Bowel Disease patients with a strong IL-17 response.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P064: IMU-838, a Small Molecule DHODH Inhibitor in Phase 2 Clinical Trial for Ulcerative Colitis, Shows Potent Anti-inflammatory Activity in Cell-Culture-Based and In Vivo Systems
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P064: Intestinal expression of LAG-3 correlates with inflammatory activity and response to biological therapy in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P064: The role of the vagal innervation in a DSS-induced colitis mouse model
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P064: TOP1210 narrow spectrum kinase inhibitor demonstrates superior activity and improved safety profile potential compared with corticosteroid and immunomodulators in preclinical models of colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P065 Metabolic utilisation of propanediol by adherent-invasive E. coli regulates intestinal tissue immunity
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P065: Altered B cell expansion and maturation in Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P065: Conservation of breast milk cytokine profiles in consecutive pregnancies of women with inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P065: Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P065: Effects of gut bacteria on the intestinal immune cell composition and barrier function
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P065: Molecular landscape of early Crohn’s disease using an integrated approach of mRNA/miRNA profiling and genomics
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P065: Olfactory receptor, OR51E2 is a marker for innate immune cells in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P065: REDD1/autophagy-driven NETosis promotes IL-1β-mediated inflammation in active ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P066 Azathioprine linked with impaired intestinal epithelial regeneration in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM